Zobrazeno 1 - 10
of 305
pro vyhledávání: '"Min Hee Hong"'
Autor:
Hye Ryun Kim, Da Hee Kim, Jung Eun Lee, Chang Gon Kim, Gamin Kim, Seyeon Park, Sang-Jun Ha, Jae-Won Cho, Martin Hemberg, Junha Cha, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Nam Suk Sim, Hyun Jun Hong, Sun Ock Yoon, Yoon Woo Koh, Insuk Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Background Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV-positive) is associated with better clinical outcomes than HPV-negative OPSCC. However, the clinical benefits of immunotherapy in patients with HPV-positive
Externí odkaz:
https://doaj.org/article/41f10413d0f440bdbb6c94e5f872b2a8
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Programmed death-ligand (PD-L1) expression serves as a predictive biomarker for immune checkpoint inhibitor (ICI) sensitivity in non-small cell lung cancer (NSCLC). Nevertheless, the development of biomarkers that reliably predict ICI res
Externí odkaz:
https://doaj.org/article/2591db794ac84f778d6314e2309f64b9
Autor:
Dong Kwon Kim, Chai Young Lee, Yu Jin Han, So Young Park, Heekyung Han, Kwangmin Na, Mi Hyun Kim, Seung Min Yang, Sujeong Baek, Youngtaek Kim, Joon Yeon Hwang, Seul Lee, Seong-san Kang, Min Hee Hong, Sun Min Lim, Jii Bum Lee, Jae Hwan Kim, Byoung Chul Cho, Kyoung-Ho Pyo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAryl hydrocarbon receptor (AhR) is a transcription factor that performs various functions upon ligand activation. Several studies have explored the role of AhR expression in tumor progression and immune surveillance. Nevertheless, investi
Externí odkaz:
https://doaj.org/article/a3b7746f9d2b48d2b48f7c6bdb67e2a9
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Identifying actionable driver mutations via tissue-based comprehensive genomic profiling (CGP) is paramount in treatment decisions for metastatic non-squamous, non-small-cell lung cancer (NSCLC). However, the role of CGP remains elusive i
Externí odkaz:
https://doaj.org/article/1ad401f8e1e84752b9834e7071188a70
Autor:
Kwangmin Na, Seul Lee, Dong Kwon Kim, Young Seob Kim, Joon Yeon Hwang, Seong-san Kang, Sujeong Baek, Chai Young Lee, Seung Min Yang, Yu Jin Han, Mi hyun Kim, Heekyung Han, Youngtaek Kim, Jae Hwan Kim, Seunghyun Jeon, Youngseon Byeon, Jii Bum Lee, Sun Min Lim, Min Hee Hong, Kyoung-Ho Pyo, Byoung Chul Cho
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionTo understand the immune system within the tumor microenvironment (TME) of non-small cell lung cancer (NSCLC), it is crucial to elucidate the characteristics of molecules associated with T cell activation.MethodsWe conducted an in-depth a
Externí odkaz:
https://doaj.org/article/f13ad274bb6e438bb19dd14aedd7d16e
Autor:
You Jin Chun, Kwang Joon Kim, Ji Yeon Lee, Ji Won Choi, Tae Hee Kim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong, Chang Oh Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 2, Pp 254-263 (2023)
Background/Aims The prognostic value of a comprehensive geriatric assessment (CGA) for the management of older small cell lung cancer (SCLC) patients remains to be established. Methods A retrospective cohort enrolled 21 SCLC patients over 65 years fr
Externí odkaz:
https://doaj.org/article/cd524618972c48deac276619385581e8
Autor:
Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang, Yulia D’yachkova, Sangmi Kim, Sam Colman, Saerom Kim, Agota Szende, Ji Hyun Park, Hee Kyung Ahn, Min Hee Hong, Kaisa-Leena Taipale, Hye Ryun Kim
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 1, Pp 131-143 (2022)
Abstract Background Despite the dynamic treatment landscape for EGFR mutant-positive metastatic non-small cell lung cancer (EGFRm+ mNSCLC), most of the earlier studies have focused on US or Western populations. Objective The objective of this study w
Externí odkaz:
https://doaj.org/article/b2648c3cdd164177984d88da2b607c6a
Autor:
Joongyo Lee, Kangpyo Kim, Kyung Hwan Kim, Ki Chang Keum, Hye Ryun Kim, Min Hee Hong, Eun Chang Choi, Se-Heon Kim, Yoon Woo Koh, Chang Geol Lee
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)
Abstract Background Human papillomavirus (HPV)-positive tonsil cancer has a better prognosis than HPV-negative tonsil cancer. Deintensification strategies to reduce or avoid radiotherapy (RT) for patients with HPV-associated tonsil cancer have been s
Externí odkaz:
https://doaj.org/article/1b2c825ded4a440aaf7904c989e107a3
Autor:
Seo Hee Choi, Andrew Jihoon Yang, Sun Och Yoon, Hye Ryun Kim, Min Hee Hong, Se-Heon Kim, Eun Chang Choi, Ki Chang Keum, Chang Geol Lee
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Purpose Although postoperative radiotherapy (PORT) is demonstrably effective in local control of head and neck adenoid cystic carcinoma (HNACC), its application is controversial and the subset of patients who would benefit most from PORT is
Externí odkaz:
https://doaj.org/article/9d9368cf85a244fe91179b3b180402e8
Autor:
Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Spartalizumab (PDR001) is a humanized IgG4 monoclonal antibody targeting programmed cell death protein 1 (PD-1). We conducted a single-arm, phase 2 trial to investigate the efficacy and safety of spartalizumab in patients with refractory esophageal s
Externí odkaz:
https://doaj.org/article/7b1070c787db4a9e95ccef4e55841573